CYRX Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
50.2M
+2.6%
49.0M
+2.5%
47.8M
+5.2%
45.5M
+2.8%
44.2M
Cost of Revenue
26.4M
+0.9%
26.1M
+1.0%
25.9M
+9.0%
23.7M
+3.6%
22.9M
Gross Profit
23.8M
+4.4%
22.8M
+4.2%
21.9M
+0.9%
21.7M
+1.8%
21.3M
Operating Expenses
32.6M
-0.7%
32.9M
+4.2%
31.5M
-0.7%
31.7M
+1.6%
31.3M
R&D
4.7M
-2.4%
4.9M
+24.2%
3.9M
-12.5%
4.5M
-1.3%
4.5M
SG&A
27.9M
-0.4%
28.0M
+1.4%
27.6M
+1.3%
27.3M
+2.0%
26.7M
Operating Income
-8804000
+12.3%
-10039000
-4.4%
-9614000
+4.2%
-10031000
-1.0%
-9932000
EBITDA
-2337000
+32.3%
-3450000
-7.4%
-3212000
+12.6%
-3676000
-4.5%
-3517000
Net Income
-10852000
-31.5%
-8255000
+21.7%
-10544000
+9.4%
-11644000
-67.7%
-6943000
EPS (Basic)
$-0.25
-25.0%
$-0.20
+20.0%
$-0.25
+7.4%
$-0.27
-50.0%
$-0.18
EPS (Diluted)
$-0.25
-25.0%
$-0.20
+20.0%
$-0.25
+7.4%
$-0.27
-50.0%
$-0.18
Shares (Diluted)
50.7M
+0.4%
50.4M
+1.1%
49.9M
-0.1%
50.0M
-0.3%
50.1M
CryoPort (CYRX) — Financials